1Carrington L M, Albon J, Anderson I, et al. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors [J]. Invest Ophthalmol Vis Sci, 2006, 47(5): 1886-1894.
2Kohama K, Nonaka K, Hosokawa R, et al. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses [J]. J Dent Res, 2002, 81(10): 688-694.
5Yamazaki K, Crowe D L, Shuler C F. Hunchback sequence binding protein suppresses mouse TGF-beta3 promoter in vitro [J]. Biochem Biophys Res Commun, 2006, 346(3): 802-809.
7ShekFW, Li KF, Mann J, et al. Transforming growth factor-beta3 express anti-fibrotic properties in pancreatic stellate cells [J]. Gut, 2004, 53(Suppl m): A16.
8Zhang Y, Liu P, Gao X L, et al. rAAV2-TGF-beta (3) decreases collagen synthesis and deposition in the liver of experimental hepatic fibrosis rat [J]. Dig Dis Sci, 2010, 55 (10):2821- 2830.
9Gordon K J, Blobe G C. Role of transforming growth factor-beta super- family signaling pathways in human disease [J]. Biochim Biophys Acta, 2008. 1782(4:. 197-228.
9Pellicoro A, Ramachandran R, Iredale JP. Reversi- bility of liver fibrosis[J]. Fibrogenesis Tissue Re- pair, 2012, 5(Suppl 1): S26.
10Tacke F. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo [J]. Fibrogenesis Tissue Repair, 2012, 5(Suppl 1): S27.
